471 related articles for article (PubMed ID: 33754804)
1. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering.
Dailey KM; Allgood JE; Johnson PR; Ostlie MA; Schaner KC; Brooks BD; Brooks AE
Future Microbiol; 2021 Mar; 16(5):341-368. PubMed ID: 33754804
[TBL] [Abstract][Full Text] [Related]
2. The microbiome and human cancer.
Sepich-Poore GD; Zitvogel L; Straussman R; Hasty J; Wargo JA; Knight R
Science; 2021 Mar; 371(6536):. PubMed ID: 33766858
[TBL] [Abstract][Full Text] [Related]
3. Methods and Techniques to Facilitate the Development of
Dailey KM; Jacobson RI; Johnson PR; Woolery TJ; Kim J; Jansen RJ; Mallik S; Brooks AE
Front Microbiol; 2021; 12():624618. PubMed ID: 33854487
[TBL] [Abstract][Full Text] [Related]
4. Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives.
Lee CH
Appl Microbiol Biotechnol; 2012 Jan; 93(2):517-23. PubMed ID: 22120621
[TBL] [Abstract][Full Text] [Related]
5. Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria.
Roe JM; Seely K; Bussard CJ; Eischen Martin E; Mouw EG; Bayles KW; Hollingsworth MA; Brooks AE; Dailey KM
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514190
[TBL] [Abstract][Full Text] [Related]
6. Microbes as Medicines: Harnessing the Power of Bacteria in Advancing Cancer Treatment.
Sawant SS; Patil SM; Gupta V; Kunda NK
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066447
[TBL] [Abstract][Full Text] [Related]
7. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
8. Current advances in bacteria-based cancer immunotherapy.
Guo C; Liu J; Zhang Y
Eur J Immunol; 2024 Feb; 54(2):e2350778. PubMed ID: 38105295
[TBL] [Abstract][Full Text] [Related]
9. The intratumoral microbiome: Characterization methods and functional impact.
Heymann CJF; Bard JM; Heymann MF; Heymann D; Bobin-Dubigeon C
Cancer Lett; 2021 Dec; 522():63-79. PubMed ID: 34517085
[TBL] [Abstract][Full Text] [Related]
10. Biosystems Engineering of Prokaryotes with Tumor-Killing Capacities.
Kalyoncu E; Olmez TT; Ozkan AD; Sarioglu OF
Curr Pharm Des; 2016; 22(11):1521-8. PubMed ID: 26654438
[TBL] [Abstract][Full Text] [Related]
11. Engineering bacteria as interactive cancer therapies.
Gurbatri CR; Arpaia N; Danino T
Science; 2022 Nov; 378(6622):858-864. PubMed ID: 36423303
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic viruses: what to expect from their use in cancer treatment.
Terrível M; Gromicho C; Matos AM
Microbiol Immunol; 2020 Jul; 64(7):477-492. PubMed ID: 31663631
[TBL] [Abstract][Full Text] [Related]
13. Microbial-based therapy of cancer: current progress and future prospects.
Bernardes N; Seruca R; Chakrabarty AM; Fialho AM
Bioeng Bugs; 2010; 1(3):178-90. PubMed ID: 21326924
[TBL] [Abstract][Full Text] [Related]
14. CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge.
Guedan S; Alemany R
Front Immunol; 2018; 9():2460. PubMed ID: 30405639
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic bacteria: past, present and future.
Rius-Rocabert S; Llinares Pinel F; Pozuelo MJ; García A; Nistal-Villan E
FEMS Microbiol Lett; 2019 Jun; 366(12):. PubMed ID: 31226708
[TBL] [Abstract][Full Text] [Related]
16. Redirecting oncolytic viruses: Engineering opportunists to take control of the tumour microenvironment.
Jamieson TR; Poutou J; Ilkow CS
Cytokine Growth Factor Rev; 2020 Dec; 56():102-114. PubMed ID: 32958389
[TBL] [Abstract][Full Text] [Related]
17. Viral Nanoparticles: Cancer Vaccines and Immune Modulators.
Fusciello M; Ylösmäki E; Cerullo V
Adv Exp Med Biol; 2021; 1295():317-325. PubMed ID: 33543466
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic viruses for cancer immunotherapy.
Hemminki O; Dos Santos JM; Hemminki A
J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470
[TBL] [Abstract][Full Text] [Related]
19. White paper on microbial anti-cancer therapy and prevention.
Forbes NS; Coffin RS; Deng L; Evgin L; Fiering S; Giacalone M; Gravekamp C; Gulley JL; Gunn H; Hoffman RM; Kaur B; Liu K; Lyerly HK; Marciscano AE; Moradian E; Ruppel S; Saltzman DA; Tattersall PJ; Thorne S; Vile RG; Zhang HH; Zhou S; McFadden G
J Immunother Cancer; 2018 Aug; 6(1):78. PubMed ID: 30081947
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ
Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
